Enoxaparin Metabolism in Reconstructive Surgery Patients
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.
Also called NCT02411292
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose other
- Phase
- Phase 2
- Enrolled
- 110 participants
- Sponsor
- Registry
-
NCT02411292
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02411292. Allocation not applicable; no masking; primary purpose other. Start 2015-03 (actual); primary completion 2016-03 (actual). Results posted on 2017-09-13.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Enoxaparin Metabolism in Reconstructive Surgery Patients
- Condition
- Venous Thromboembolism
- Condition
- Deep Venous Thrombosis
- Condition
- Pulmonary Embolus
- Condition
- Reconstructive Surgery
- Intervention (Drug)
- Enoxaparin
- Lead sponsor
- University of Utah
Record details
- Record id
cardio:ct-nct02411292- Content hash
f508e557bd38a1be95cdb6692a145173245f33b619f4bff3498adf93fb6989f1